Speeches and presentations

30 November 2023

Getting ahead of Respiratory Diseases with GSK management

GSK management held a virtual event on 30 November at 8:00 AM EST / 1:00 PM GMT. The event featured a presentation and an interactive Q&A session. A replay is available on demand.

29 November 2023

Evercore ISI HealthCONx Conference

Phil Dormitzer, SVP and Global Head Vaccines R&D and Infectious Disease Research, discussed the progress being made in vaccine innovation during a fireside chat at the Evercore ISI HealthCONx Conference on Wednesday, 29 November 2023, 12:30pm UK / 7:30am ET.

29 November 2023

Redburn Atlantic CEO Conference

Luke Miels, Chief Commercial Officer, discussed the progress being made at GSK during a fireside chat at the Redburn Atlantic CEO Conference on Wednesday, 29 November 2023 at 9:00am UK.

16 November 2023

Jefferies London Healthcare Conference

Tony Wood, Chief Scientific Officer, participated in a fireside chat at the Jefferies London Healthcare Conference on Thursday, 16 November at 9:00am GMT.

28 September 2023

Getting ahead of HIV with ViiV Healthcare management

ViiV Healthcare management held a virtual event on 28 September at 9:00 AM EDT / 2:00 PM BST. The event, "Getting ahead of HIV," featured a presentation and an interactive Q&A. A recording of the session is available on YouTube.

14 September 2023

BofA 2023 Global Healthcare Conference

Emma Walmsley, Chief Executive Officer, participated in a fireside chat at the BofA Global Healthcare Conference on Thursday 14 September at 09:05 BST.

07 September 2023

Citi’s 18th Annual BioPharma Conference

Phil Dormitzer, SVP, Head of Vaccines R&D joined Andrew Baum in a fireside chat at Citi’s 18th Annual BioPharma Conference which took place Thursday, September 7th at 8:50am ET/1:50pm UK.

27 June 2023

Getting ahead of Infectious Disease with GSK management

The virtual event featured a presentation, four breakout sessions and an interactive Q&A. Recordings of all sessions are available on YouTube.

13 June 2023

Goldman Sachs’ 44th Annual Global Healthcare Conference

Tony Wood, Chief Scientific Officer, discussed progress made in R&D during a fireside chat on Tuesday, 13 June at 9:20am PT/12:20pm ET/5:20pm UK during Goldman Sachs’ 44th Annual Global Healthcare Conference, in Dana Point, California.

06 June 2023

ESG Investor Education Event (Clinical Trial Diversity)

During the 45 minute session Alberto Fernandez, SVP of Global Clinical Operations at GSK and Dr. Kimberly Smith, SVP and Head of R&D at ViiV Healthcare, provided insights on the importance of clinical trial diversity including support from a 17-year retrospective study. During the session, the leaders also provided an overview of GSK’s work to ensure clinical trials reflect the populations most impacted by a disease and explored a HIV case study that demonstrated the power of clinical trial diversity in action. The presentation was followed by an opportunity for audience Q&A.

10 January 2023

41st annual JP Morgan Healthcare Conference

Emma Walmsley, Chief Executive Officer, presented at the 41st annual JP Morgan Healthcare Conference on Tuesday 10 January at 07:30-08:10am PT / 15:30-16:10 GMT. The 40 minute session included a presentation and a moderated Q&A discussion. 

30 November 2022

Evercore ISI HealthCONx Conference

Deborah Waterhouse, Chief Executive Officer of ViiV Healthcare, and Dr. Kimberly Smith, Head of R&D at ViiV Healthcare, discussed the progress being made in HIV innovation during a fireside chat at the Evercore ISI HealthCONx Conference Wednesday, November 30^th, 1pm UK / 8:00am ET.

16 November 2022

Jefferies London Healthcare Conference

David Redfern, Chief Strategy Officer, participated in a fireside chat at the Jefferies London Healthcare Conference on Wednesday, 16 November 2022 at 09:45 GMT.

28 October 2022

Response to Investor Forum Letter

GSK’s response to an Investor Forum letter, regarding GSK’s redefined operating model post-Demerger.

21 October 2022

Investor science event: Getting ahead of respiratory syncytial virus in older adults

After presenting the positive AReSVi-006 pivotal phase III results for our RSV (respiratory syncytial virus) older adults vaccine candidate at IDWeek 2022, GSK management hosted an investor science event on 21 October 2022.

16 September 2022

BofA 2022 Global Healthcare Conference

Emma Walmsley, CEO, participated in a fireside chat at the BofA Global Healthcare Conference on Friday 16 September at 0815 BST.

07 September 2022

Citi 17th Annual BioPharma Conference

Roger Connor, President Global Vaccines & Global Health and Phil Dormitzer, SVP, Head of Vaccines R&D joined Andrew Baum in a fireside chat at Citi’s 17th Annual BioPharma Conference which took place Wednesday, September 7 at 1:50pm ET/6:50pm UK. 

14 June 2022

dbAccess Global Consumer Conference 2022

Tobias Hestler, CFO GSK Consumer Healthcare participated in a fireside chat at the dB Access Global Consumer Conference on 14th June 2022 at 14:45pm BST (15:45pm CEST, 9:45am EDT).

13 June 2022

Goldman Sachs 43rd Annual Global Healthcare Conference..

Deborah Waterhouse, CEO, ViiV Healthcare, and Dr. Kimberly Smith, Head of R&D, ViiV Healthcare, discussed progress being made in the HIV space during a fireside chat at the Goldman Sachs 43rd Annual Global Healthcare Conference, Monday, June 13^th at 10:00pm UK / 5:00pm ET

24 May 2022

UBS Global Healthcare Conference 2022

Dr. Kimberly Smith, Head of R&D, ViiV Healthcare, discussed progress being made in HIV innovation during a fireside chat at the UBS Global Healthcare Conference on Tuesday, May 24^th at 2:15pm UK / 9:15am ET.​

20 May 2022

JPMorgan CEO Consumer Staples fireside chat series

Brian McNamara, CEO Designate of Consumer Healthcare, participated in a fireside chat with JPMorgan analyst Celine Pannuti as part of her series of discussions with consumer staples CEOs. In the conversation Brian discussed the growth outlook across various consumer health categories, recent innovation trends and progress towards becoming a standalone company. 

05 April 2022

ESG Investor Education Event (Environment)

Claire Lund, Vice President Environmental Sustainability, hosted our first ESG Investor Education Event focusing on our environment strategy, 5 April 2022 at 15:00 BST / 10:00 EDT.

09 March 2022

UBS Global Consumer and Retail Conference 2022

Tobias Hestler, CFO Designate of Consumer Healthcare, participated in a fireside chat at the UBS Global Consumer and Retail Conference hosted by UBS analyst Guillaume Delmas.

07 March 2022

Cowen 42nd Annual Health Care Conference

Hal Barron, Chief Scientific Officer and President R&D, discussed the progress GSK is making in R&D during a fireside chat at the Cowen 42nd Annual Health Care Conference taking place virtually on Monday, 7 March 2022 at 4:10pm UK/11:10pm ET.

28 February 2022

GSK Consumer Healthcare Capital Markets Day

GSK's Consumer Healthcare Capital Markets Day took place on Monday 28 February 2022. This event provided details on our strategy, brands, capabilities and operations, as well as detailed financial information and future growth ambitions ahead of the proposed listing on the London Stock Exchange following the anticipated demerger from GSK mid-2022.

10 February 2022

FCLT Global presents “Investing in Healthcare Innovations: A Case Study of Multi-stakeholder Capitalism in Practice"

Roger Connor, President Global Vaccines & Global Health, particpated in a panel hosted by FCLT Global on Thursday, February 10^th at 8:00am ET/1:00pm GMT.  The panel focused on navigating the complexity of long-term strategies and investment since financing healthcare advancements, and particularly vaccine development, became central priority with the onset of COVID19.

11 January 2022

JP Morgan Healthcare Conference 2022

Emma Walmsley, Chief Executive Officer, presented at the 40th annual JP Morgan Healthcare Conference on Tuesday 11 January at 07:30-08:10am ET / 12:30-13:10 GMT. The 40 minute session included a presentation and a moderated Q&A discussion. 

06 January 2022

Goldman Sachs 14th Annual Healthcare CEOs Unscripted Conference

Emma Walmsley, Chief Executive Officer, participated in the Goldman Sachs 14th Annual Healthcare CEOs Unscripted Conference: A View from the Top, on Thursday, 6 January 2022 at 8:00am ET.

02 December 2021

Morgan Stanley ESG Insights Conference 2021

Harmony Garges, SVP and Chief Medical Officer ViiV Healthcare, presented at the virtual Morgan Stanley ESG Insights Conference and provided an overview of ViiV’s mission to leave no person living with HIV behind and how it aligns with ViiV’s ESG efforts.

01 December 2021

Redburn CEO conference 2021

Brian McNamara, CEO of GSK Consumer Healthcare, participated in a virtual fireside chat at the 2021 Redburn CEO Conference. He provided an overview of our business and broader industry.

29 November 2021

Meet GSK management: getting ahead of HIV

GSK hosted a ‘Meet GSK management’ event on 29 November 2021 at 15:00 GMT / 10:00 EST.

09 November 2021

UBS European Conference 2021

Tobias Hestler, CFO GSK Consumer Healthcare, participated in a virtual fireside chat at the UBS European Conference hosted by analyst Guillaume Delmas.

07 November 2021

Investor science event: ASN Kidney Week 2021

GSK held an investor science event for daprodustat’s ASCEND Phase III programme at 12 noon EST/ 5pm GMT on 7 November 2021.

07 October 2021

The Investor Forum

Sir Jonathan Symonds, Chairman, and Manvinder Singh Banga, Senior Independent Non-Executive Director, participated in an Investor Forum meeting on Thursday 7 October 2021.

06 October 2021

Guggenheim 2nd Annual Vaccine and Infectious Disease Day

Rino Rappuoli, Senior Vice President Global Head of Vaccines R&D, will participate in a fireside chat at Guggenheim’s 2^nd Annual Vaccine and Infectious Disease Day taking place Wednesday 6 October 2021 at 1:00pm ET. 

22 September 2021

Bernstein Annual Pan European Strategic Decisions Conference

Tobias Hestler, CFO for GSK Consumer Healthcare participated in a virtual fireside chat at the Bernstein Annual Pan European Strategic Decisions Conference.

17 September 2021

BofA 2021 Global Healthcare Conference

Emma Walmsley, CEO, participated in a fireside chat at the BofA Global Healthcare Conference on Friday 17 September at 0815 BST.

10 September 2021

Barclay’s Global Consumer Staples conference

Brian McNamara, CEO GSK Consumer Healthcare, joined a virtual fireside chat hosted by Barclay’s analyst, Iain Simpson.  He provided an overview of the Consumer Healthcare business and our category leading brands. 

09 September 2021

Citi 16th Annual Biopharma Conference

Dr. Kimberly Smith, Head of R&D, ViiV Healthcare participated in a fireside chat at Citi’s 16th Annual Biopharma Conference taking place on Thursday 9 September 2021 at 18:25 UK / 1:25pm EDT. Dr. Smith provided an update on ViiV Healthcare’s progress in advancing HIV science and R&D.

29 June 2021

Guggenheim’s Biopharma Strategy Series

Hal Barron, Chief Scientific Officer and President R&D, joined a virtual fireside chat hosted by Guggenheim analyst Seamus Fernandez at Guggenheim’s Biopharma Strategy Series.

The event, 'Biopharma's Next Decade: Views from the Top on Global Strategy and Innovation' took place Tuesday, 29 June 2021 at 19:00 BST / 14:00 EDT, during which he provided an update on the progress GSK is making in R&D.

23 June 2021

New GSK Investor update

Emma Walmsley, CEO, and other members of CET hosted a virtual investor update at 14:00-17:30 BST on Wednesday 23 June. The update provided a clear view of the strategy for New GSK, its outlook for growth and the opportunities we see for shareholder value creation.

10 June 2021

Exane BNP Paribas 23rd European CEO Conference

Brian McNamara, CEO, GSK Consumer Healthcare, presented at the conference and provided an introduction to GSK Consumer Healthcare and outlined our purpose, strategy, category-leading brands and capabilities, as well as an overview of the consumer healthcare sector.

08 June 2021

CECP Biopharma Investor Forum

Emma Walmsley, CEO, presented at CECP’s Biopharma Investor Forum on Tuesday 8 June at 8:40 EST/13:40 BST, during which she provided an overview on our approach to ESG. The presentation was followed by a moderated Q&A session.

10 March 2021

Barclays Global Healthcare Conference 2021

Deborah Waterhouse, CEO of ViiV Healthcare, participated in a fireside chat at the Barclays Global Healthcare Conference on Wednesday, March 10 at 8:35am ET/1:35pm GMT, during which she provided an update on the progress GSK is making in the HIV space.

01 March 2021

Cowen 41st Annual Health Care Conference

Hal Barron, Chief Scientific Officer and President R&D, participated in a fireside chat at the Cowen 41st Annual Health Care Conference on Monday, March 1 2021 at 5:20pm GMT /12:20pm ET, during which he discussed updates on the progress GSK is making in R&D.

11 February 2021

Guggenheim Healthcare Talks 2021

Axel Hoos, GSK Senior Vice-President Oncology R&D, joined a Fireside Chat with Seamus Fernandez at the Guggenheim Healthcare Talks 2021 Oncology Days, Thursday, February 11, at 10AM ET, where the duo discussed GSK Oncology R&D progress.

11 January 2021

39th annual JP Morgan Virtual Healthcare Conference

Hal Barron, Chief Scientific Officer and President R&D, presented at the 39th annual JP Morgan Virtual Healthcare Conference on Tuesday 12 January at 10:50-11:30am ET / 15:50-16:30 GMT.  The presentation was followed by a Q&A session. 

05 January 2021

Goldman Sachs 13th Annual Healthcare Unscripted CEOs Conference

Emma Walmsley, CEO, hosted a fireside chat at the Goldman Sachs 13th annual healthcare unscripted CEOs conference on Tuesday 5 January at 12:00 GMT

09 December 2020

Morgan Stanley ESG Insights Conference

Phil Thomson, President Global Affairs, hosted a fireside chat at the Morgan Stanley ESG Insights Conference on Wednesday, 9 December 2020 at 15:25 GMT / 10:25am EST.

01 December 2020

Evercore ISI HealthCONx Conference

Luke Miels, President Global Pharmaceuticals, hosted a fireside chat at Evercore ISI HealthCONx Conference on Tuesday, 1 December 2020 at 13:00 GMT / 8:00am EST, during which provided an update on the progress GSK is making in the global pharmaceuticals and vaccines business.

22 October 2020

Investor and analyst call to discuss RSV vaccines data

GSK held an investor and analyst call hosted by Hal Barron, Chief Scientific Officer and President R&D, Roger Connor, President, GSK Vaccines, and Emmanuel Hanon, SVP and Head of Vaccines R&D, and discussed data on two respiratory syncytial virus (RSV) vaccine candidates to be presented at ID Week.

This event took place on Thursday 22 October at 3:30pm CET / 2:30pm BST / 9:30am EDT.

17 September 2020

BofA Global Healthcare Conference

Emma Walmsley, CEO, hosted a fireside chat at the BofA Global Healthcare Conference on Thursday 17 September at 0815 BST.

09 September 2020

Citi 15th Annual Biopharma Conference

Hal Barron, Chief Scientific Officer and President R&D, will host a fireside chat at the Citi 15th Annual Biopharma Conference taking place Wednesday 9 September 2020 at 16:40 BST/11:40am EDT, during which he will provide an update on the progress GSK is making in the R&D pipeline.

09 July 2020

Investor and analyst call to discuss HIV Prevention Treatment Network 083 study

GSK held an investor/analyst call hosted by David Redfern, Chief Strategy Officer of GSK and Chairman of ViiV Healthcare, Deborah Waterhouse, CEO, ViiV Healthcare and Dr. Kimberly Smith, Head of R&D, ViiV Healthcare to discuss the final efficacy analysis from the global HIV Prevention Treatment Network (HPTN) 083 study evaluating investigational long-acting cabotegravir for HIV prevention.

This event took place on: Thursday 9 July at 14:00 BST / 09:00 EDT

13 February 2020

Guggenheim Healthcare Talks Idea Forum, New York City

Axel Hoos, Senior Vice-President Oncology R&D, hosted a Fireside Chat at the Guggenheim Healthcare Talks Idea Forum, Oncology Day, held in New York City on Thursday, February 13th, during which he provided an update on GSK Oncology R&D progress.

14 January 2020

38th annual JP Morgan Healthcare Conference, San Francisco

Emma Walmsley, CEO, presented at the 38th annual JP Morgan Healthcare Conference in San Francisco on Tuesday 14 January, and provided an overview of GSK’s priorities and the progress the company made during 2019.  The presentation was followed by a Q&A session. 

17 December 2019

Investor and Analyst call from DREAMM-2 data

On Tuesday, 17 December 2019 at 17:00 GMT / 12:00 EST, Hal Barron, Chief Scientific Officer and President of R&D, Luke Miels, President Pharmaceuticals and Axel Hoos, SVP Oncology R&D hosted an investor/analyst conference call to discuss GSK’s pivotal DREAMM-2 data on belantamab mafodotin (GSK’916).

30 September 2019

Investor and Analyst call from ESMO 2019

On Monday, 30 September 2019, Dr Hal Barron, Chief Scientific Officer and President R&D and Luke Miels, President, GSK Global Pharmaceuticals hosted an investor conference call following the presentation of the PRIMA data on Zejula (niraparib) and the INDUCE-1 data on GSK’609 (ICOS) at the 2019 European Society for Medical Oncology (ESMO) congress. The call also featured participation from an external expert in ovarian cancer and other GSK senior oncology leaders.

26 September 2019

GSK Vaccines Investor Event

Roger Connor, President, GSK Vaccines, hosted an educational session on GSK’s Vaccines business at our manufacturing site in Wavre, Belgium on Thursday 26 September at 13:30 CET / 12:30 BST / 7:30 EDT.

12 June 2019

Goldman Sachs’ 40th Annual Global Healthcare Conference, California

Hal Barron, Chief Scientific Officer and President R&D, hosted a fireside chat at Goldman Sachs’ 40^th Annual Global Healthcare Conference, which took place in Rancho Palos Verdes, California on Wednesday 12 June, during which he has provided an update on the progress being made in GSK’s R&D organisation.

06 June 2019

Jefferies 2019 Healthcare Conference, New York

David Redfern, Chief Strategy Officer of GSK and Chairman of ViiV Healthcare, and Deborah Waterhouse, CEO of ViiV Healthcare, hosted a fireside chat at the Jefferies 2019 Healthcare Conference in New York on Thursday 6 June, during which they provided an update on the progress GSK and ViiV Healthcare have made this year.

04 June 2019

Bernstein Consumer Healthcare & Nutrition Seminar, London

Tobias Hestler, CFO GSK Consumer Healthcare, hosted a fireside chat at the Bernstein Consumer Healthcare & Nutrition Seminar in London on Tuesday 4 June during which he provided an update on the Consumer Healthcare business and the formation of a new, world-leading Consumer Healthcare joint venture.

30 April 2019

ViiV Healthcare analyst call

David Redfern, Chairman ViiV Healthcare, Deborah Waterhouse, CEO ViiV Healthcare and Dr Kimberly Smith, VP Global Research & Medical Strategy hosted a ViiV Healthcare analyst call on Tuesday 30 April to discuss ViiV Healthcare’s recent regulatory activities and provide an update on the pipeline.

12 March 2019

Cowen & Co. 39th Annual Health Care Conference, Boston

Luke Miels, President Global Pharmaceuticals, hosted a fireside chat at the Cowen & Co. 39th Annual Health Care Conference 2019 in Boston on Tuesday 12 March, during which he provided an update on the progress GSK is making in the global pharmaceuticals and vaccines business.

28 February 2019

SVB Leerink Global Healthcare Conference, New York

Brian McNamara, CEO GSK Consumer Healthcare, hosted a fireside chat at the 8th Annual SVB Leerink Global Healthcare Conference that took place in New York City on Thursday 28 February during which he provided an update on the Consumer Healthcare business and the formation of a new, world-leading Consumer Healthcare joint venture.

14 February 2019

Guggenheim Healthcare Talks Idea Forum, New York

Axel Hoos, SVP Oncology R&D, hosted a Fireside Chat at the Guggenheim Healthcare Talks Idea Forum - Oncology Day held in New York City on Thursday 14 February during which he provided an update on GSK Oncology R&D progress.

08 January 2019

37th annual JP Morgan Healthcare Conference, San Francisco

Emma Walmsley, CEO, gave a presentation at the 37th annual JP Morgan Healthcare Conference in San Francisco on Tuesday 8 January, providing an overview of GSK’s priorities and the progress the company made during 2018.

19 December 2018

Analyst call on formation of new Consumer Healthcare JV

On Wednesday 19 December 2018, GSK announced an agreement with Pfizer Inc to combine their consumer health businesses into a new world-leading Joint Venture. A call for investors and analysts was hosted by Emma Walmsley, Chief Executive Officer, Brian McNamara, CEO GSK Consumer Healthcare and Simon Dingemans, Chief Financial Officer.

10 December 2018

ViiV Meet the Management, London

David Redfern, Chairman ViiV Healthcare and Deborah Waterhouse, CEO ViiV Healthcare along with members of the ViiV Healthcare leadership team hosted a ViiV Healthcare Investor Event on Monday 10 December in London. The event included presentations from David, Deborah, Dr Kimberly Smith Global Research & Medical Strategy, Eric Dube Head of North America and Dr John Pottage Chief Scientific & Medical Officer and was followed by a Q&A session

05 December 2018

Citi 2018 Global Healthcare Conference, New York

Hal Barron, Chief Scientific Officer and President, R&D hosted a fireside chat at the Citi 2018 Global Healthcare Conference held in New York City on Wednesday 5 December, in which he provided an overview of GSK’s R&D priorities and progress made during 2018.

03 December 2018

Analyst call on agreement to acquire TESARO

On Monday, 3 December 2018, GSK announced an agreement to acquire TESARO, an oncology-focused company based in the US. A call for investors and analysts was hosted by Emma Walmsley, Chief Executive Officer, Simon Dingemans, Chief Financial Officer, Dr Hal Barron, Chief Scientific Officer and President R&D, and Luke Miels, President, GSK Global Pharmaceuticals.

28 November 2018

Evercore ISI HealthConX Conference, Boston

Deborah Waterhouse, CEO, and Dr Kimberly Smith, Head of Global Research and Medical Strategy, ViiV Healthcare, hosted a fireside chat at the Evercore ISI HealthConX Conference held in Boston, Massachusetts on Wednesday 28 November, during which they provided an overview of ViiV’s priorities and progress made during 2018.

23 October 2018

Investor and Analyst call on GSK’165 aGM-CSF data presented at ACR

On Tuesday, 23 October 2018, Dr Hal Barron, Chief Scientific Officer and President R&D and Luke Miels, President, GSK Global Pharmaceuticals hosted an investor conference call following the presentation of efficacy and safety data on GSK3196165, GSK's anti-GM-CSF antibody in development for Rheumatoid Arthritis at the 2018 American College of Rheumatology (ACR). The call also featured participation from an external expert in rheumatology and GSK’s Medicine Development Lead for GSK’165.

21 September 2018

Consumer Healthcare investor event, New Jersey

Brian McNamara, CEO GSK Consumer Healthcare, and members of his leadership team hosted an investor event to review the Consumer Healthcare business. This event included a tour of our Shopper Science, Consumer Sensory and R&D labs, as well as presentations from Brian McNamara, Marc Speichert, SVP Digital and Richard Slater, SVP R&D, followed by a Q&A session.

20 September 2018

CECP CEO Investor Forum

Emma Walmsley, CEO, spoke at CECP’s CEO Investor Forum on Thursday 20 September 2018 about the steps we are taking to build trust – one of our three long-term priorities – and drive sustainable business performance.

13 September 2018

Bank of America Merrill Lynch Global Healthcare Conference, London

Emma Walmsley, CEO, gave a presentation at the Bank of America Merrill Lynch Global Healthcare Conference in London on Thursday 13 September 2018 in which she provided an overview of GSK’s priorities and progress made during 2018.

24 July 2018

GEMINI Results of HIV 2 Drug Regimen Investor & Analyst Update

On Tuesday, 24 July 2018, GSK hosted an investor conference call following the presentation of the full set of scientific and clinical data on GSK’s 2 drug regimen of dolutegravir plus lamiviudine (GEMINI studies) in treatment naïve HIV patients at the 22nd International AIDS Conference.

The call was hosted by David Redfern, GSK Chief of Strategy and Chairman of ViiV Healthcare, Deborah Waterhouse, CEO of ViiV Healthcare, John Pottage, Chief Scientific & Medical Officer of ViiV Healthcare, and Kimberly Smith, VP Global Research & Medical Strategy of ViiV Healthcare.

13 June 2018

Goldman Sachs 39th Annual Healthcare Conference, California

David Redfern, Chief Strategy Officer, hosted a fireside chat at the Goldman Sachs 39th Annual Healthcare Conference in Rancho Palos Verdes, California on Wednesday 13 June, in which he provided an overview of GSK’s priorities and progress made during 2018.

06 June 2018

Jefferies 2018 Healthcare Conference, New York City

David Redfern, Chief Strategy Officer, hosted a fireside chat at the Jefferies 2018 Healthcare Conference in New York City on Wednesday 6 June, in which he provided an overview of GSK’s priorities and progress made during 2018.

27 March 2018

Consumer Healthcare Update, London

On Tuesday, 27 March 2018, GSK reached an agreement with Novartis to acquire full ownership of the Consumer Healthcare business. A call for investors and analysts was hosted by Emma Walmsley, Chief Executive Officer, Simon Dingemans, Chief Financial Officer and Brian McNamara, CEO, Consumer Healthcare.

09 January 2018

36th annual JP Morgan Healthcare Conference, San Francisco, US

Emma Walmsley, CEO, gave a presentation at the 36th annual JP Morgan Healthcare Conference in San Francisco about our business outlook, as well as our latest product approvals and advances in our pipeline.

12 December 2017

GSK Oncology Investor & Analyst Update

On Tuesday, 12 December 2017, GSK hosted an investor conference call following the presentation of scientific and clinical data on GSK2857916, GSK's anti-BCMA (B-cell Maturation Antigen) antibody-drug conjugate presented at the 59th American Society of Hematology (ASH) annual meeting.

The call was hosted by Luke Miels, President, GSK Global Pharmaceuticals and Axel Hoos, SVP and Therapy Area Head of Oncology R&D. The call also featured participation from an external expert in multiple myeloma.

07 December 2017

Citi Global Healthcare Conference, New York

Axel Hoos, SVP – Oncology R&D, participated in a fireside chat at the Citi Global Healthcare Conference on December 7 in New York.

30 November 2017

Evercore conference, Boston

David Redfern, Chief Strategy Officer and Chairman of ViiV Healthcare, Deborah Waterhouse, CEO of ViiV Healthcare and Kim Smith, Vice President, Global Medical Strategy, ViiV Healthcare, participated in a fireside chat at the Evercore ISI 2017 Biopharma Catalyst/Deep Dive Conference in Boston on Thursday, November 30.

29 November 2017

Consumer Healthcare investor event

Brian McNamara, CEO GSK Consumer Healthcare, and members of his leadership team hosted an investor event to review the Consumer Healthcare business. This event included a tour of our Shopper Science and Consumer Sensory labs, as well as presentations from Brian McNamara and Richard Slater, SVP, R&D Consumer Healthcare, followed by a Q&A session.

26 July 2017

Investor event, London 2017

The investor event outlined the Group’s key priorities including presentations from Emma Walmsley, CEO, and Simon Dingemans, CFO.

08 March 2017

Cowen 37th Annual Healthcare Conference

Axel Hoos, SVP – Oncology R&D, gave a presentation at the Cowen and Company 37^th Annual Health Care Conference  in Boston. Axel provided an overview of GSK’s Oncology strategy and pipeline.

15 February 2017

Investor event at CROI 2017, Seattle

ViiV Healthcare Chairman David Redfern, CEO Dominique Limet and Chief Scientific and Medical Officer John Pottage, hosted an investor event following the presentation of the SWORD Phase III data at the Conference on Retroviral and Opportunistic Infections.

10 January 2017

35th annual JP Morgan Healthcare Conference, San Francisco, USA

Dr Patrick Vallance, President, R&D gave a presentation at the 35th annual JP Morgan Healthcare Conference in San Francisco, providing an overview of the company’s pharmaceutical pipeline.

29 November 2016

Meet the Vaccines management

Luc Debruyne and his leadership team hosted an investor event to review the Vaccines business. This event included a tour of the Wavre site, presentations from Luc Debruyne, Thomas Breuer, Manu Hanon and John McGrath, followed by a Q&A session.

19 September 2016

HIV and ViiV Healthcare presentation to Goldman Sachs

Seminar on the evolving scientific and commercial landscape for HIV and ViiV Healthcare. Presentation by Dr Dominique Limet and Dr John Pottage followed by a Q&A session.

02 September 2016

Meet The Respiratory Management event

Prior to the 2016 ERS conference, senior respiratory leaders Eric Dube, Neil Barnes and Dave Allen hosted an investor event with presentations and a Q&A session to review the Respiratory business.

08 June 2016

Goldman Sachs 37th Annual Global Healthcare Conference

Simon Dingemans, Chief Financial Officer, participated in a fireside chat to discuss progress on GSK’s business strategy and addressed questions before a large group of investors at the Goldman Sachs Conference in California on Wednesday, 8 June 2016.

24 February 2016

Citi Healthcare Bus Tour, New York

Dr. Axel Hoos, SVP, Therapeutic Area Head for Oncology R&D and Head of Immuno-Oncology, hosted an investor event organized by Citi at their offices in New York. Axel provided an overview of GSK’s strategy and pipeline in Immuno-Oncology.

10 February 2016

Leerink Partners 5th Annual Global Healthcare Conference

Simon Dingemans, Chief Financial Officer, addressed questions in front of a large group of US investors at the Leerink Partners 5th Annual Global Healthcare Conference on Wednesday, February 10 in New York. Simon provided an overview of GSK’s 2015 full year results and outlook for the future. The webcast of the event will be archived for 90 days.

12 January 2016

34th Annual JP Morgan Healthcare Conference, San Francisco USA

Andrew Witty, CEO, gave a presentation at the 34th Annual JP Morgan Healthcare Conference in San Francisco, providing an overview of progress the company has made during 2015.

18 December 2015

David Redfern

David Redfern, Chief Strategy Officer, discusses the two transactions with Bristol-Myers Squibb to acquire their late-stage HIV pipeline assets and also their pre-clinical and discovery stage research assets.

03 November 2015

R&D event

On Tuesday 3 November, we hosted an event focusing on our R&D pipeline. This provided a unique insight into the innovative medicines and vaccines that GSK is developing for the future.

06 May 2015

Investor event

The Investor event outlined the Group’s strategy for 2015 and beyond including presentations from the heads of our Vaccines, Pharmaceuticals and Consumer businesses together with Sir Andrew Witty, Chief Executive Officer and Simon Dingemans, Chief Financial Officer.

06 May 2015

Investor event

The Investor event outlined the Group’s strategy for 2015 and beyond including presentations from the heads of our Vaccines, Pharmaceuticals and Consumer businesses together with Sir Andrew Witty, Chief Executive Officer and Simon Dingemans, Chief Financial Officer.

13 January 2015

33rd Annual JP Morgan Healthcare Conference

David Redfern, Chief Strategy Officer, gave a presentation at the 33th Annual JP Morgan Healthcare Conference in San Francisco.

19 September 2014

Bank of America Merrill Lynch Global Healthcare Conference, London UK

Simon Dingemans, Chief Financial Officer, gave a presentation at the Bank of America Merrill Lynch Global Healthcare conference in London on 19th September 2014. Simon provided an overview of the recent results and the shape of the company going forward.

24 February 2014

Citi Global Healthcare Conference, New York USA

Andrew Witty, CEO, presented at the Citi Global Healthcare Conference on February 24, 2014 in New York. Andrew opened with a few minutes of brief remarks followed by a 'fireside chat' question and answer session.

24 February 2014

Investor Event at ERS 2014, Munich

Darrell Baker, Senior Vice President, Head of Global Respiratory Franchise hosted an investor event comprising a presentation and Q&A session based on data presented at ERS.

14 January 2014

32nd Annual JP Morgan Healthcare Conference, San Francisco USA

Simon Dingemans, Chief Financial Officer, gave a presentation at the 32nd Annual JP Morgan Healthcare Conference in San Francisco. Simon provided an overview of the progress being made in implementing the company’s strategy.

06 December 2013

Leerink Swann PolarXpress, Philadelphia

Dr Paolo Paoletti, President of GSK Oncology, hosted an investor event organized by Leerink Swann at the GSK offices in Philadelphia.

22 August 2013

North Carolina CEO Forum

Deirdre Connelly, President, North America Pharmaceuticals, spoke at the North Carolina CEO Forum about the importance of curiosity, vision, flexibility, and risk-taking to create a high-performing, innovative, and sustainable business.

12 June 2013

Goldman Sachs 34th Annual Global Healthcare Conference, California USA

David Redfern, Chief Strategy Officer, gave a fireside chat on GSK’s business strategy and addressed questions in front of a large group of US investors at the Goldman Sachs Conference in California on Wednesday 12 June 2013.

21 May 2013

Investor Event at ATS 2013, Philadelphia

Darrell Baker, Senior Vice President, Head of Global Respiratory Franchise hosted an investor event comprising a short presentation and Q&A session based on data presented at ATS.

13 February 2013

Leerink Swann Healthcare Conference

Simon Dingemans, Chief Financial Officer, addressed questions in front of a large group of US investors at the Leerink Swann Global Healthcare Conference on Wednesday, February 13 in New York.  Simon provided an overview of GSK’s 2012 full year results and outlook for the future.

09 January 2013

Late-stage pipeline review - Patrick Vallance

Patrick Vallance, President, Pharmaceutical R&D gave a presentation at the 31st Annual JP Morgan Healthcare Conference in San Francisco. Patrick provided a review of the progress being made on the late stage pipeline.

04 December 2012

Late-stage pipeline review - Sir Andrew Witty, Dr Moncef Slaoui, and Dr Patrick Vallance

Sir Andrew Witty (CEO), Dr Moncef Slaoui (Chairman of R&D) and Dr Patrick Vallance (President of Pharmaceutical R&D) together with senior R&D leaders hosted a seminar focusing on GSK’s late stage pipeline. The event brought together the progress made in 2012, as Phase III programmes for a significant number of potential new drugs have concluded. It also provided an overview of our progress on our returns driven strategy in R&D and the sustainability of our pipeline.

05 November 2012

Annual Pharmaceutical Regulatory and Compliance Congress

Deidre Connelly, President North America Pharmaceuticals, spoke at the 13th Annual Pharmaceutical Regulatory and Compliance Congress about how we conduct our business.

01 October 2012

Investor Meeting at ESMO, Vienna

Dr Paolo Paoletti, President of GSK Oncology, hosted an investor event in conjunction with data presented at the European Society for Medical Oncology.

27 July 2012

Investor Meeting at IAC, Washington

ViiV Healthcare Chairman David Redfern, CEO Dominique Limet and Chief Scientific and Medical Officer, John Pottage, hosted an investor event at the International AIDS Conference (IAC).

09 June 2012

Investor Meeting at ADA, Philadelphia

Dr Carlo Russo, Senior Vice President and Head of Albiglutide Development hosted an investor event in conjunction with data presented at the American Diabetes Association meeting.

04 June 2012

Investor Meeting at ASCO, Chicago

Paolo Paoletti, President of GSK Oncology, hosted an investor event in conjunction with data presented at the American Society of Clinical Oncology (ASCO) meeting.

15 May 2012

World Affairs Council, Philadelphia

Deirdre Connelly, President, North America Pharmaceuticals, gave a speech at the World Affairs Council (WAC) in Philadelphia about how the challenges and opportunities facing the pharmaceutical business.

29 March 2012

R&D Seminar

Moncef Slaoui, Chairman of Research & Development and Patrick Vallance, President, Pharmaceuticals R&D, presented a live webcast - Capital Allocation in R&D and a DPU Deep Dive.

21 March 2012

PharmEHR Summit, Philadelphia

Deirdre Connelly, President, North America Pharmaceuticals, gave a speech at PharmEHR Summit in Philadelphia about how GSK sees healthcare evolving and how electronic health records fit into that shifting landscape.

10 January 2012

Annual JP Morgan Healthcare Conference

Simon Dingemans, Chief Financial Officer, gave a presentation at the 30th Annual JP Morgan Healthcare Conference in San Francisco.  Simon provided an overview of the progress being made in implementing GSK’s strategy.

01 December 2011

Core Earnings Reporting

Simon Dingemans, Chief Financial Officer discusses the methodology GSK will use for its core earnings reporting to begin with effect from Q1 2012.

14 November 2011

Credit Suisse Healthcare Conference, Hong Kong

Abbas Hussain, President, Emerging Markets & Asia Pacific gave a presentation at the Credit Suisse Asia Healthcare Conference in Hong Kong.  Abbas provided an overview of GSK's emerging markets strategy.

05 May 2011

Bernstein Conference, New York

Adrian Rawcliffe, SVP Finance North American Pharmaceuticals, presented at the Bernstein Pharma Conference: “Pharmaceutical R&D Productivity: Diagnosing the Problem & Searching for Solutions” in New York City. The conference was attended by over 100 investors. Ad discussed GSK’s R&D Strategy and its Focus on Return on Investment.

23 March 2011

Citi’s Seminar in London on Vaccines in Emerging Markets

Martin Andrews, SVP – Global Vaccines Centre of Excellence, GSK Biologicals, gave a presentation on GSK’s vaccines business at Citi’s Seminar in London on Vaccines in Emerging Markets.

17 March 2011

Andrew Witty presents to the US State Department

GSK CEO Andrew Witty presented at the United States Department of State symposium, “The Role of Innovation in Addressing Global Health”. In his address, which was convened to discuss advances and ways of working together to overcome diseases of the developing world, Andrew expanded upon GlaxoSmithKline’s commitments in this area.

10 March 2011

Presentation to investors

Abbas Hussain, President, Emerging Markets, gave a presentation to a small group of investors, where he provided an overview of GSK's emerging markets strategy.

08 March 2011

Cowen and Company 31st Annual Health Care Conference

Patrick Vallance, SVP – Medicines Discovery and Development, gave a presentation at the Cowen and Company 31st Annual Health Care Conference in Boston. Patrick provided an overview of GSK’s R&D Strategy and its Focus on Return on Investment.

21 February 2011

CED Biotech/Life Science Conference

Deirdre Connelly, President, North American Pharmaceuticals, addressed the CED Biotech/Life Science Conference in Raleigh, Durham, on 21 February 2011.

10 February 2011

The Economist Pharma Summit

David Redfern, GSK Chief Strategy Officer, was one of the two keynote speakers at The Economist Pharma Summit Reinventing Pharma for a New Generation  on 10 February 2011 in London. He outlined GSK’s strategic priorities, our innovative approach to pricing and the value of our late stage pipeline coupled with our ongoing efforts to drive the effectiveness of R&D.

24 January 2011

CBI 8th Annual Pharmaceutical Compliance Conference

Deirdre Connelly, President, North American Pharmaceuticals, addressed the 8th annual Center for Business Intelligence (CBI) pharmaceutical compliance conference on 24 January. Deirdre spoke about what the pharmaceutical industry must do to build trust.

12 January 2011

JP Morgan Healthcare Conference

David Redfern, Chief Strategy Officer at GlaxoSmithKline, gave a presentation at the 29th Annual JP Morgan Healthcare Conference in San Francisco.  David provided an overview of the progress being made in implementing GSK’s strategy.

09 December 2010

CEO Andrew Witty discusses R&D and drug discovery on BBC Radio 4

CEO Andrew Witty discusses R&D and drug discovery on BBC Radio 4.

02 December 2010

Eddie Gray, President GSK Pharma Europe, speaks at FT pharmaceutical conference

The 27th annual FT Global Pharmaceutical & Biotechnology Conference took place in London on 1–2 December 2010. The event brought together thought-leaders from the pharmaceutical industry, patient groups, regulators, health technology assessment (HTA) groups to share insights and discuss the future for healthcare and the role of the pharmaceutical industry.

01 December 2010

CLSA China Conference

Mark Reilly, GM, Pharmaceuticals China & Hong Kong, gave a presentation at the CLSA China Conference on December 1 in New York City. Mark gave an update on GSK’s strategy and progress in its pharmaceuticals business in China.

22 November 2010

CEO Andrew Witty featured in The World in 2011

In The World in 2011, published in November 2010 by The Economist, Andrew Witty, CEO of GlaxoSmithKline, calls on the pharmaceutical industry to do more with less—and still be innovative.

19 November 2010

Mind the Medicine Gap

In this Open University programme on global access to medicines, Jon Pender of GlaxoSmithKline discusses the importance of intellectual property and why it is a critical mechanism to allow companies to generate funds for reinvestment to help create the medicines of the future.The programme also discusses how pharmaceutical companies can help to tackle neglected tropical diseases and improve access to medicines in developing nations.

10 November 2010

Credit Suisse Healthcare Conference, Phoenix, AZ

Deirdre Connelly, President, North America Pharmaceuticals, gave a presentation at the 2011 Annual Credit Suisse Healthcare Conference in Phoenix, AZ on 10 November. The presentation was attended by institutional investors and portfolio managers. Deirdre provided an overview of GSK’s US Pharmaceuticals business.

10 November 2010

Credit Suisse Healthcare Conference

Andrew Witty, Chief Executive Officer, gave a presentation at the 2010 Annual Credit Suisse Health Care Conference in Phoenix, AZ. The presentation was attended by over 100 institutional investors and portfolio managers. Andrew provided an overview of the progress being made in implementing the company's strategy.

22 September 2010

Sanford C. Bernstein Pan-European Strategic Decisions Conference

Julian Heslop (CFO) gave a presentation at the Sanford C. Bernstein 7th Pan-European Strategic Decisions Conference in London.  Julian provided an overview of GSK’s Half Year 2010 results and an outlook for the future.

17 September 2010

Bank of America/Merrill Lynch Global Healthcare Conference

Julian Heslop (CFO) gave a presentation at the BoA/Merrill Lynch Healthcare Conference in London.  Julian provided an overview of GSK’s Half Year 2010 results and an outlook for the future.

23 June 2010

Investor Meeting with John Clarke, President, Worldwide Consumer Healthcare

John Clarke (President, Worldwide Consumer Healthcare), along with senior members of his management team, presented on GSK's Consumer Healthcare business.

21 June 2010

Investor Visit to GSK Biologicals, Wavre, Belgiu

Dr Thomas Breuer (Senior Vice President, Head of Global Development, GSK Biologicals) presented on GSK’s vaccines business.

16 June 2010

Goldman Sachs Thirty-First Annual Health Care Conference in California

Andrew Witty gave the keynote speech regarding the Pharmaceutical Industry and GSK's strategy at the Goldman Sachs Thirty-First Annual Health Care Conference in California.

01 June 2010

Slides Presented at Investor Meetings in June

This is a general slide deck presented at investor meetings during June 2010.

26 May 2010

2010 Citi Investment Research Global Health Care Conference in New York

Simon Harford (SVP, Finance, Emerging Markets) participated on a panel at the 2010 Citi Investment Research Global Health Care Conference in New York. The panel was entitled "The Opportunities and Challenges of Emerging Markets for Health Care"

12 January 2010

JP Morgan 28th Annual Healthcare Conference

Andrew Witty (CEO) gave a presentation to investors at the JP Morgan 28th Annual Healthcare Conference in San Francisco. Andrew provided an overview of the progress being made in implementing the company's strategy.